25 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Natural Capsules Ltd.

BSE

  • 78.40 0.80 (1.03%)
  • Vol: 171
  • BSE Code: 524654
  • PREV. CLOSE
    77.60
  • OPEN PRICE
    77.90
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    78.40(49)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Natural Capsules Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
24-Jan-201731-Jan-2017 Quarterly Results
20-Oct-201627-Oct-2016 Quarterly Results
18-Aug-201626-Aug-2016 Preferential Issue of shares Natural Capsules Ltd has informed BSE that a meeting of the Board of Directors of the company is scheduled to be held on August 26, 2016, inter alia, to consider and approve the allotment of equity shares to promoters shareholders on preferential issue basis.
22-Jul-201630-Jul-2016 Quarterly Results
30-May-201628-May-2016 Dividend
10-May-201628-May-2016 Audited Results
18-Jan-201627-Jan-2016 The Board of Directors of the Company will be held on January 27, 2016, inter alia, to consider the following business as under:- 1. To consider and approve the unaudited financial results for the quarter ended December 31, 2015 and submit to auditor of the company for limited review as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015. 2. To consider and approve Listing agreement between BSE limited and NCL as per Annexure I of SEBI (listing obligation and Disclosure requirement) Regulations, 2015. & Quarterly Results
19-Oct-201529-Oct-2015Natural Capsules Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 29, 2015, inter alia, to consider the following business as under: 1. To consider and approve the unaudited financial results for the quarter ended September 30, 2015 and submit to auditor of the Company for limited review as per Clause 41 of the Listing Agreement. 2. To consider and analyse the current business activities of M/s. Supreem Pharmaceuticals Mysore Pvt. Ltd.
11-Aug-201514-Aug-2015Natural Capsules Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 14, 2015, inter alia, to consider the following business as under:-. 1. To consider and approve the pending share warrant conversion to equity share allotment to promoters (preferential issue) 2. To consider the current status of investment in a pharmaceutical company.
27-Jul-201529-Jul-2015 The Board of Directors, inter alia will consider a preferential Allotment of shares and warrants to the promoters and others in the Board meeting to be held on July 29, 2015.
24-Jul-201529-Jul-2015 The Board of Directors, inter alia will consider a preferential Allotment of shares and warrants to the promoters and others in the Board meeting to be held on July 29, 2015.
29-May-201530-May-2015 Audited Results
05-Feb-201510-Feb-2015 The Board of Directors of the Company will be held on February 10, 2015, inter alia, to consider the following business: 1. To consider allotment of 2,20,000 Equity Shares of Rs. 10/- each on conversion of warrants issued as per the terms approved by the Members in the EGM held on February 20, 2014.
22-Jan-201529-Jan-2015 Quarterly Results